---
title: "Alpha Tau issues press release on ADMIRE study in recurrent cSCC patients"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292767316.md"
description: "Alpha Tau Medical issued a press release regarding the successful first treatment in its ADMIRE trial for immunocompromised patients with recurrent cutaneous squamous cell carcinoma (cSCC). The procedure was conducted at Banner MD Anderson Cancer Center. This update follows the completion of enrollment in the company's ReSTART pivotal trial for recurrent cSCC."
datetime: "2026-07-15T12:32:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292767316.md)
  - [en](https://longbridge.com/en/news/292767316.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292767316.md)
---

# Alpha Tau issues press release on ADMIRE study in recurrent cSCC patients

-   Alpha Tau posted a press release on successful first treatment in its ADMIRE trial using Alpha DaRT for immunocompromised patients with recurrent cSCC. \* Procedure took place at Banner MD Anderson Cancer Center in Arizona; trial targets patients typically excluded from cSCC studies. \* Update follows completion of enrollment in the ReSTART pivotal trial for recurrent cSCC. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alpha Tau Medical Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607150830PRIMZONEFULLFEED9762282) on July 15, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [DRTS.US](https://longbridge.com/en/quote/DRTS.US.md)
- [DRTSW.US](https://longbridge.com/en/quote/DRTSW.US.md)

## Related News & Research

- [Alpha Tau Posts Strong Alpha DaRT–Keytruda Data in Head and Neck Cancer Study](https://longbridge.com/en/news/293346278.md)
- [Alpha Tau Medical notifies availability of press release on Alpha DaRT-pembrolizumab head and neck cancer data](https://longbridge.com/en/news/293342055.md)
- [Puma Alpha VCT Confirms Share Capital and Voting Rights Total](https://longbridge.com/en/news/294537113.md)
- [Weak Statutory Earnings May Not Tell The Whole Story For Alpha IVF Group Berhad (KLSE:ALPHA)](https://longbridge.com/en/news/294447757.md)
- [Is Alpha Cognition (NASDAQ:ACOG) In A Good Position To Invest In Growth?](https://longbridge.com/en/news/294355366.md)